查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587078

醫療保健領域的生成式人工智慧市場：按組件、按功能、按應用、按最終用戶、按地區、機會、預測，2017-2031 年

Generative AI in Healthcare Market Assessment, By Component, By Function, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 228 Pages | 商品交期: 3-5個工作天內

價格

全球醫療保健領域的生成人工智慧市場規模將從 2023 年的 11.5 億美元增至 2031 年的 77.6 億美元，預計在 2024-2031 年期間複合年增長率為 26.95%。產生人工智慧 (AI) 在醫療保健中的整合有可能改善患者護理、加速醫學研究和個人化治療計劃。透過利用這項尖端技術的潛力，醫療保健提供者可以獲得前所未有的效率、創新和精確度。此外，生成式人工智慧模型可以透過瞭解原始資料的底層資料分佈並產生與原始資料在統計上相同的資料來產生合成資料。

市場上的主要參與者也在增加對健康科技公司的投資，以利用數位創新並改變醫療保健產業。 2024 年 10 月，Google LLC 宣佈對 Ubie Inc. 進行重大投資，以改造日本的醫療保健系統。該公司的人工智慧症狀檢查器 "Ubie" 、 "Ubie Medical Navigator" 和 "Ubie for pharma" 為每位患者提供量身定制的指導和症狀評估，指導他們進行適當的醫療護理。該公司的人工智慧系統檢查器每月透過提供個人化指導和評估症狀幫助超過 1200 萬人獲得所需的護理，而該公司的醫療導航器則幫助患者簡化入院流程並提高諮詢品質。這項投資還旨在改善該公司提供的系統，以改善患者的治療效果。

人工智慧的各種應用推動了生成式人工智慧在醫療保健領域的日益普及，包括增強的臨床判斷、治療模擬和資料擷取。生成人工智慧也正在發展成為一個重要的學術研究領域，它具有潛力，可以透過設計治療方法、產生治療模型的合成數據和藥物發現等應用來徹底改變產業。

本報告調查了全球醫療保健領域的生成人工智慧市場，包括市場概述、按組件、功能、應用、最終用戶、地區以及進入市場的公司的概況劃分的趨勢。

目錄

第一章專案範圍與定義

第二章研究方法

第 3 章執行摘要

第 4 章全球醫療保健市場生成式人工智慧展望，2017-2031 年

  • 市場規模分析與預測
  • 市佔率分析與預測
  • 2023 年市場地圖分析
    • 按組件
    • 按功能
    • 依用途
    • 按最終用戶
    • 按地區

第五章北美醫療保健生成人工智慧市場展望，2017-2031

第 6 章歐洲醫療保健市場生成式人工智慧的前景，2017-2031

第 7 章亞太地區醫療保健市場生成式人工智慧展望，2017-2031 年

第 8 章2017-2031 年南美洲醫療保健生成式人工智慧市場展望

第 9 章 2017-2031 年中東及非洲醫療保健領域的生成式 AI 市場前景

第10章供需分析

第11章價值鏈分析

第十二章波特五力分析

第 13 章 PESTLE 分析

第14章價格分析

第 15 章市場動態

第16章市場趨勢與發展

第 17 章監理架構與創新

第十八章專利狀況

第 19 章案例研究

第20章競爭態勢

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 名進入公司的 SWOT 分析
  • 市場前10位主要參與者的情況
    • Oracle Corporation
    • Alphabet Inc.
    • Syntegra
    • Nvidia Corporation
    • Microsoft Corporation
    • Insilico Medicine
    • International Business Machines Corporation
    • Abridge AI, Inc.
    • OpenAI OpCo, LLC
    • DiagnaMed Holdings Ltd.

第21章策略建議

第二十二章查詢及免責聲明

Product Code: MX12201

Global generative AI in healthcare market is projected to witness a CAGR of 26.95% during the forecast period 2024-2031, growing from USD 1.15 billion in 2023 to USD 7.76 billion in 2031. The integration of generative artificial intelligence (AI) in the healthcare sector has the potential to improve patient care, accelerate medical research, and personalize treatment plans. By harnessing the potential of this cutting-edge technology, healthcare providers can access unprecedented levels of efficiency, innovation, and accuracy in their practices. Additionally, generative AI models can generate synthetic data by comprehending the underlying data distribution from the original data and then generating one that is statistically the same as the original data.

The leading market players are also increasingly investing in health tech companies to leverage digital innovations and transform the healthcare sector. In October 2024, Google LLC announced a significant investment in Ubie Inc. to transform Japan's healthcare system. The company's Ubie AI symptom checker, Ubie Medical Navigator, and Ubie for pharma guide patients to appropriate medical care by providing personalized guidance and assessing their symptoms. The company's AI system checker aids over 12 million individuals every month in accessing the required medical care by providing personalized guidance and assessing their symptoms, whereas their medical navigator streamlines the patient intake process and improves the quality of medical consultation. The investment also aims to improve the systems provided by the company to improve patient outcomes.

The rising adoption of generative AI in healthcare can also be attributed to the different applications of AI in enhancing clinical decisions, treatment simulations, and data extraction. Generative AI is also evolving as a crucial discipline for research and has the potential to revolutionize the industry by enabling applications, including treatment approach design, synthetic data generation for treatment models, and drug discovery, among others.

Novel Launches Boost Market Growth

The growing efforts of various software companies to bolster the development and availability of generative AI solutions for healthcare applications is one of the major factors propelling the global generative AI in healthcare market growth. In October 2024, Weave Communications, Inc. announced the launch of their AI-powered Call Intelligence product to transform healthcare practices for leveraging and analyzing call data, boosting operational efficiency, and elevating patient experiences. By deploying Wave's custom generative AI model, healthcare professionals can extract actionable insights and gain comprehensive information from patient interactions.

Additionally, in October 2024, Microsoft Corporation also unveiled new healthcare AI agent services and models for connecting care experiences, empowering healthcare professionals, enhancing team collaborations, and providing operational and clinical insights.

Increasing Collaborations and Partnerships Support Market Expansion

In October 2024, Kipu Health LLC, one of the leading providers of technological solutions for behavioral health, announced a collaboration with Amazon Web Services, Inc. to bring innovative AI solutions for streamlining clinical workflow by providing chart summaries, transcribing patient sessions, and generating progress notes. With the collaboration, the companies aim to unite cutting-edge technology with behavioral health expertise to reduce the administrative burden on therapy providers and clinicians, allowing them to focus on the patients. The Kipu Intelligence Program is going to leverage Amazon Web Service's AI services to develop ethical AI solutions that will ensure data governance, transparency, and patient safety. Such efforts of the leading companies are expected to bolster the availability of novel AI solutions and provide lucrative growth opportunities to the market.

Additionally, companies are also collaborating to make healthcare systems that are preventive and predictive instead of reactive. In August 2024, GE HealthCare Technologies Inc. and Amazon.com, Inc. announced a partnership to create artificial intelligence models to aid clinicians in sorting mass volumes of patient data in an efficient manner. GE HealthCare plans on using Amazon's Bedrock to build generative AI applications to allow clinics and hospitals to gain insights and access to enhance patient care with the help of comprehensive data sets. Such partnerships and collaborations are expected to aid healthcare professionals in detecting health issues in a time-efficient manner, improving and enhancing patient outcomes, and providing lucrative growth opportunities to the market.

Hospitals Account for Significant Market Share

Generative AI has emerged as a transformative tool for improving patient outcomes and has the potential to revolutionize clinical decision making by generating new data including images and text. Technology also promises to expand treatment outcomes, revolutionize disease diagnosis, and improve patient care. Various hospitals across the world are deploying generative AI models for reducing the workload of healthcare professionals and optimizing the diagnostic and treatment processes. In November 2023, Chi Mei Medical Center, Tainan, Taiwan, rolled out multiple copilots or generative AI assistants that were built with Microsoft Corporations' Azure OpenAI Service. Generative AI assistants aid doctors in generating progress notes and medical reports from admission, ensuring time efficiency. The copilots are also being used by nutritionists and nurses in the medical center. In May, generative AI was used about 36,000 times for 3,500 individuals.

Similarly, in August 2024, Kaiser Foundation Health Plan, Inc. (Kaiser Permanente) partnered with Abridge AI, Inc. to roll out latter's generative AI clinical tech in their 40 hospital systems. The integrated nonprofit also rolled out generative AI at over 600 medical offices across Washington D.C. and eight other states.

North America Holds Major Market Share

The rapid growth of the market in North America can be attributed to the increasing implementation and adoption of advanced AI solutions in various countries across the region and the presence of a well-established healthcare sector, increasing the ease of integration of novel technologies. North America houses some of the leading healthcare organizations and med tech companies, further increasing their accessibility to novel technologies that have significant applications in healthcare, including generative AI. Additionally, the United States is increasingly deploying AI agents from clinical settings to research laboratories. For instance, a team of researchers at the National Cancer Institute (NCI) are using various AI models for annotating and segmenting 3D CT imaging. Meanwhile, a team at the National Institutes of Health's (NIH) National Center for Advancing Translational Sciences (NCATS) is using generative AI-based virtual screening for reducing the cost and time of developing new drug molecules. Furthermore, generative AI is also being used for designing novel proteins that are promising drug candidates. The Genetic and Rare Diseases Information Center is exploring the development of generative AI tools to enhance their ability to gather data from the previously hard to reach databases.

Future Market Scenario (2024 - 2031F)

As per the global generative AI in healthcare market analysis, the market is expected to witness significant demand in the coming years due to the rapid population growth and expansion of the healthcare industry. According to the estimates of the United Nations, in 2050, the global population is expected to be 9.7 billion, and by mid-2080s, the population is expected to reach approximately 10.4 billion. This rapid growth is expected to increase the burden on the medical industry and healthcare professionals, increasing the dependency on generative AI and providing lucrative growth opportunities to the market. Additionally, the integration of generative AI with other novel technologies including Internet of Things (IoT), among others is also expected to enhance its capabilities, allowing for real-time patient monitoring and secure data sharing. Generative AI is also expected to accelerate diagnostic processes by analyzing large amounts of medical information in a time efficient manner and allowing healthcare organizations to provide more personalized therapies and medications. Generative AI is also expected to go beyond traditional AI in the near future and open doors for a new era of accelerated innovation, personalized medicine, and improved efficiency.

Key Players Landscape and Outlook

The rising efforts of the market players towards the introduction of new technologies propels the growth of the global generative AI in healthcare market. In May 2023, DiagnaMed Holdings Ltd. announced the launch of FormGPT.io (www.FormGPT.io), a generative AI data analysis and collection solution that has applications in the healthcare sector. The first commercial product of the company, FormGPT.io is a part of their initiative to launch a suite of customizable and generative AI ready-made applications that are powered by GPT-4 for improving operational workflow and efficiency and supporting real-world situations in enhancing patient outcomes. Additionally, FromGPT.io also aims to improve patient outcomes and engagement as well as user services and workflow.

Similarly, in September 2023, Oracle Corporation announced new generative AI services for healthcare organizations. Their new Oracle Clinical Digital Assistant is integrated with the company's electronic health record solutions, allowing healthcare professionals to leverage generative AI with voice commands to reduce manual tasks and improve patient care. Such developments aid in reducing errors and improving the quality of care provided to the patients as the digital assistant simplifies administrative tasks, allowing physicians to give their complete attention to patients.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Generative AI in Healthcare Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Component
      • 4.2.1.1. Solutions
      • 4.2.1.2. Services
    • 4.2.2. By Function
      • 4.2.2.1. Virtual Nursing Assistants
      • 4.2.2.2. Robot-Assisted AI Surgery
      • 4.2.2.3. Administrative Process Optimization
      • 4.2.2.4. Medical Imaging Analysis
    • 4.2.3. By Application
      • 4.2.3.1. Treatment
      • 4.2.3.2. Diagnosis
      • 4.2.3.3. Drug Discovery and Development
      • 4.2.3.4. Research
    • 4.2.4. By End-user
      • 4.2.4.1. Hospitals and Clinics
      • 4.2.4.2. Healthcare Companies
      • 4.2.4.3. Diagnostic Centers
      • 4.2.4.4. Clinical Research
      • 4.2.4.5. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia-Pacific
      • 4.2.5.4. South America
      • 4.2.5.5. Middle East and Africa
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Component
    • 4.3.2. By Function
    • 4.3.3. By Application
    • 4.3.4. By End-user
    • 4.3.5. By Region

5. North America Generative AI in Healthcare Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Component
      • 5.2.1.1. Solutions
      • 5.2.1.2. Services
    • 5.2.2. By Function
      • 5.2.2.1. Virtual Nursing Assistants
      • 5.2.2.2. Robot-Assisted AI Surgery
      • 5.2.2.3. Administrative Process Optimization
      • 5.2.2.4. Medical Imaging Analysis
    • 5.2.3. By Application
      • 5.2.3.1. Treatment
      • 5.2.3.2. Diagnosis
      • 5.2.3.3. Drug Discovery and Development
      • 5.2.3.4. Research
    • 5.2.4. By End-user
      • 5.2.4.1. Hospitals and Clinics
      • 5.2.4.2. Healthcare Companies
      • 5.2.4.3. Diagnostic Centers
      • 5.2.4.4. Clinical Research
      • 5.2.4.5. Others
    • 5.2.5. By Country Share
      • 5.2.5.1. United States
      • 5.2.5.2. Canada
      • 5.2.5.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Generative AI in Healthcare Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Component
          • 5.3.1.2.1.1. Solutions
          • 5.3.1.2.1.2. Services
        • 5.3.1.2.2. By Function
          • 5.3.1.2.2.1. Virtual Nursing Assistants
          • 5.3.1.2.2.2. Robot-Assisted AI Surgery
          • 5.3.1.2.2.3. Administrative Process Optimization
          • 5.3.1.2.2.4. Medical Imaging Analysis
        • 5.3.1.2.3. By Application
          • 5.3.1.2.3.1. Treatment
          • 5.3.1.2.3.2. Diagnosis
          • 5.3.1.2.3.3. Drug Discovery and Development
          • 5.3.1.2.3.4. Research
        • 5.3.1.2.4. By End-user
          • 5.3.1.2.4.1. Hospitals and Clinics
          • 5.3.1.2.4.2. Healthcare Companies
          • 5.3.1.2.4.3. Diagnostic Centers
          • 5.3.1.2.4.4. Clinical Research
          • 5.3.1.2.4.5. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Generative AI in Healthcare Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Generative AI in Healthcare Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Generative AI in Healthcare Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Generative AI in Healthcare Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

  • 15.1. Market Drivers
  • 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

  • 17.1. Regulatory Policies
  • 17.2. Innovations

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

  • 20.1. Competition Matrix of Top 5 Market Leaders
  • 20.2. SWOT Analysis for Top 5 Players
  • 20.3. Key Players Landscape for Top 10 Market Players
    • 20.3.1. Oracle Corporation
      • 20.3.1.1. Company Details
      • 20.3.1.2. Key Management Personnel
      • 20.3.1.3. Products and Services
      • 20.3.1.4. Financials (As Reported)
      • 20.3.1.5. Key Market Focus and Geographical Presence
      • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 20.3.2. Alphabet Inc.
    • 20.3.3. Syntegra
    • 20.3.4. Nvidia Corporation
    • 20.3.5. Microsoft Corporation
    • 20.3.6. Insilico Medicine
    • 20.3.7. International Business Machines Corporation
    • 20.3.8. Abridge AI, Inc.
    • 20.3.9. OpenAI OpCo, LLC
    • 20.3.10. DiagnaMed Holdings Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 3. Global Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 4. Global Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 5. Global Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 6. Global Generative AI in Healthcare Market Share (%), By Region, 2017-2031F
  • Figure 7. North America Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 8. North America Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 9. North America Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 10. North America Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 11. North America Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 12. North America Generative AI in Healthcare Market Share (%), By Country, 2017-2031F
  • Figure 13. United States Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 14. United States Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 15. United States Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 16. United States Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 17. United States Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 18. Canada Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 19. Canada Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 20. Canada Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 21. Canada Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 22. Canada Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 23. Mexico Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 24. Mexico Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 25. Mexico Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 26. Mexico Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 27. Mexico Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 28. Europe Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 29. Europe Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 30. Europe Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 31. Europe Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 32. Europe Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Generative AI in Healthcare Market Share (%), By Country, 2017-2031F
  • Figure 34. Germany Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 35. Germany Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 36. Germany Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 37. Germany Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 38. Germany Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 39. France Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 40. France Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 41. France Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 42. France Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 43. France Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 44. Italy Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 45. Italy Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 46. Italy Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 47. Italy Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 48. Italy Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 49. United Kingdom Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 50. United Kingdom Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 51. United Kingdom Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 52. United Kingdom Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 53. United Kingdom Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 54. Russia Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 55. Russia Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 56. Russia Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 57. Russia Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 58. Russia Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 59. Netherlands Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 60. Netherlands Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 61. Netherlands Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 62. Netherlands Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 63. Netherlands Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 64. Spain Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Spain Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 66. Spain Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 67. Spain Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 68. Spain Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 69. Turkey Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 70. Turkey Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 71. Turkey Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 72. Turkey Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 73. Turkey Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 74. Poland Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. Poland Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 76. Poland Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 77. Poland Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 78. Poland Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 79. South America Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 80. South America Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 81. South America Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 82. South America Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 83. South America Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 84. South America Generative AI in Healthcare Market Share (%), By Country, 2017-2031F
  • Figure 85. Brazil Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 86. Brazil Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 87. Brazil Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 88. Brazil Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 89. Brazil Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 90. Argentina Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 91. Argentina Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 92. Argentina Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 93. Argentina Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 94. Argentina Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 95. Asia-Pacific Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 96. Asia-Pacific Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 97. Asia-Pacific Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 98. Asia-Pacific Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 99. Asia-Pacific Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 100. Asia-Pacific Generative AI in Healthcare Market Share (%), By Country, 2017-2031F
  • Figure 101. India Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. India Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 103. India Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 104. India Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 105. India Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 106. China Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 107. China Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 108. China Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 109. China Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 110. China Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 111. Japan Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 112. Japan Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 113. Japan Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 114. Japan Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 115. Japan Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 116. Australia Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 117. Australia Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 118. Australia Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 119. Australia Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 120. Australia Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 121. Vietnam Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 122. Vietnam Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 123. Vietnam Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 124. Vietnam Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 125. Vietnam Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 126. South Korea Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. South Korea Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 128. South Korea Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 129. South Korea Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 130. South Korea Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 131. Indonesia Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 132. Indonesia Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 133. Indonesia Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 134. Indonesia Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 135. Indonesia Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 136. Philippines Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 137. Philippines Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 138. Philippines Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 139. Philippines Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 140. Philippines Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 141. Middle East & Africa Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 142. Middle East & Africa Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 143. Middle East & Africa Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 144. Middle East & Africa Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 145. Middle East & Africa Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 146. Middle East & Africa Generative AI in Healthcare Market Share (%), By Country, 2017-2031F
  • Figure 147. Saudi Arabia Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 148. Saudi Arabia Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 149. Saudi Arabia Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 150. Saudi Arabia Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 151. Saudi Arabia Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 152. UAE Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 153. UAE Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 154. UAE Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 155. UAE Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 156. UAE Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 157. South Africa Generative AI in Healthcare Market, By Value, In USD Billion, 2017-2031F
  • Figure 158. South Africa Generative AI in Healthcare Market Share (%), By Component, 2017-2031F
  • Figure 159. South Africa Generative AI in Healthcare Market Share (%), By Function, 2017-2031F
  • Figure 160. South Africa Generative AI in Healthcare Market Share (%), By Application, 2017-2031F
  • Figure 161. South Africa Generative AI in Healthcare Market Share (%), By End-user, 2017-2031F
  • Figure 162. By Component Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163. By Function Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023